Cancer & Metabolism

Papers
(The TQCC of Cancer & Metabolism is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The diversity and breadth of cancer cell fatty acid metabolism110
Fructose contributes to the Warburg effect for cancer growth77
DHODH and cancer: promising prospects to be explored70
Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer62
Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI61
Tumor-associated collagen signatures: pushing tumor boundaries40
Pyruvate carboxylase and cancer progression39
Mitochondrial metabolism as a target for acute myeloid leukemia treatment33
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma32
Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines26
SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice25
Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer24
Modulating pyrimidine ribonucleotide levels for the treatment of cancer24
A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism22
Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth22
Glutamine uptake and utilization of human mesenchymal glioblastoma in orthotopic mouse model22
Metabolite AutoPlotter - an application to process and visualise metabolite data in the web browser22
Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma21
Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement21
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer20
ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism18
Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase18
Mass spectrometry imaging of L-[ring-13C6]-labeled phenylalanine and tyrosine kinetics in non-small cell lung carcinoma18
The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer17
Pharmacological activation of pyruvate kinase M2 reprograms glycolysis leading to TXNIP depletion and AMPK activation in breast cancer cells17
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover17
RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination15
In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells15
PHGDH supports liver ceramide synthesis and sustains lipid homeostasis15
Inflammatory metabolic profile of South African patients with prostate cancer15
Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition14
Glutaminolysis dynamics during astrocytoma progression correlates with tumor aggressiveness14
Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP114
Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models14
0.072557926177979